Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
N Engl J Med
.
2021 Mar 18;384(11):e42.
doi: 10.1056/NEJMc2036175.
Authors
José A Moura-Neto
1
,
Claudio Ronco
2
Affiliations
1
Bahiana School of Medicine and Public Health, Salvador, Brazil moura@nephrologyworldwide.com.
2
University of Padua, Padua, Italy.
PMID:
33730469
DOI:
10.1056/NEJMc2036175
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Humans
Naphthyridines
Renal Insufficiency, Chronic* / complications
Substances
Naphthyridines
finerenone